sequence could be detected in a test genome. Given its high throughput, shotgun-SBH could work well as a resequencing platform for the discovery of single nucleotide polymorphisms or mutations in coding and noncoding exons, which represent nearly 2% of the human genome (55 megabases) and can be harvested using exon-capture technologies 7, 8 .
How does shotgun-SBH compare with other DNA sequencing platforms? Whereas other platforms require polymerases or ligases, shotgun-SBH uses only a universal set of synthetic locked nucleic acid oligonucleotides, which are stable and inexpensive reagents. Although loss of DNA fragments during sample preparation produced gaps in the E. coli genome sequence, this loss is not an inherent property of the method, and new sample preparation techniques could substantially improve assembly beyond the observed 80%.
The DNA fragment length used in shotgun-SBH is 200 bases, functionally analogous to the read-length of other methods and roughly comparable to the 300-base reads obtained with Roche's Genome Sequencer FLX. Compared with Roche's FLX technology, shotgun-SBH achieves greater parallelism because the density of sequencing features can be as high as 10 million per square centimeter. Other commercial next-generation sequencers-Illumina's Solexa sequencing-by-synthesis platform and Applied Biosystems' SOLiD sequencing-by-ligation platform-offer a similar degree of miniaturization, but the reads are only 30-40 bases long. However, paired-end sequencing, achievable with the Roche FLX, Illumina and ABI SOLiD platforms, captures genomic fragments of known length, facilitating de novo assembly of complex genomes-a task that remains beyond the capabilities of shotgun-SBH.
In a recent report from Helicos Biosciences, Harris et al. 9 describe the first single-molecule sequencing-by-synthesis technology. Is shotgun-SBH single-molecule sequencing? Yes and no. The DNA fuzz balls interrogated during shotgun-SBH are indeed single molecules of DNA with the caveat that each fuzz ball contains many tandem copies of the same sequence; thus, this is not single-molecule sequencing in the strict sense. Nonetheless, it is interesting to compare shotgun-SBH with the Helicos technology. Harris et al. 9 reported a novel cycling chemistry for DNA sequencingby-synthesis that generated 30-base reads with high parallelism (280,000 simultaneous reads) and enabled sequencing of a viral genome. The method requires washing steps for each cycle but does not require cloning or DNA amplification and is therefore not prone to loss of DNA fragments. The success rate for detecting base substitutions was 98%, slightly better than shotgun-SBH, whereas the throughput and read lengths were lower in the Helicos report.
On the horizon are other single-molecule sequencing technologies from Visigen Biotechnologies and Pacific Biosciences. These companies are developing different approaches based on real-time massively parallel imaging of single-molecule base-addition events catalyzed by DNA polymerase. Data are generated at a rate of 10-50 bases per second per polymerase molecule, as tens of thousands of polymerases read DNA templates. Read lengths of 8,000 bases may be within reach, making these technologies ideal for the most challenging applications, like sequencing of structurally rearranged cancer cell genomes. Although shotgun-SBH may not be well suited to tackling genome rearrangements, its potential for extremely high parallelism through inexpensive scaling of the imaging area could give it a cost advantage in standard genome resequencing applications.
Nearly 20 years have elapsed since SBH was first envisioned and the sequencing of single molecules of DNA was proposed 10 . We are now on the cusp of a new era in which widely available high-throughput platforms will generate DNA sequence information from any organism at a cost of pennies per megabase.
Targeted mutagenesis in zebrafish
Ian G Woods & Alexander F Schier Directed gene knockout in a vertebrate has been achieved using zincfinger nucleases.
Random mutagenesis of the zebrafish genome using chemicals, retroviruses or transposons has uncovered mutations in hundreds of genes 1 . The ability to engineer specific mutations, however, has remained elusive. Two papers in this issue, by Meng et al. 2 and Doyon et al. 3 , introduce a method for targeted mutagenesis in zebrafish. Both studies employ zinc-finger nucleases (ZFNs)-chimeric molecules consisting of a DNA-binding zinc-finger domain and the FokI restriction endonuclease-to induce mutations in specific zebrafish genes (Fig. 1 ). This technique makes it possible to disrupt any gene of interest and may facilitate more sophisticated manipulations of the zebrafish genome.
ZFNs induce targeted double-strand breaks in the genome [4] [5] [6] . The specificity of DNA cleavage is conferred by varying a ZFN's repertoire of zinc fingers, each of which interacts with a particular triplet of DNA base pairs. Combining three or four zinc fingers allows specific binding to 9-or 12-bp motifs, respectively. Double-strand breaks occur when two ZFNs bind to target DNA, bringing their nuclease domains together. Active only as a dimer, the nuclease domains cleave the DNA between the bound ZFNs.
The endogenous double-strand-break repair machinery can then edit the genome through two pathways. If a matching template sequence is available, repair can occur by homologous recombination. In the absence of a template, the DNA can be religated by nonhomologous end joining, often with the addition or deletion of bases. The ability of ZFNs to induce targeted doublestrand breaks has been exploited in numerous applications, including the creation of knockouts in cell lines 7 and invertebrates 8 and gene editing in mammalian cells 9 .
Both Meng et al. 2 and Doyon et al. 3 use ZFNs to generate mutations through nonhomologous end joining: mRNAs encoding two ZFNs are injected into fertilized eggs, and ZFN activity is assayed by PCR 2 and phenotypic screening 3 in the injected fish and their progeny (Fig. 1) Both groups also show that ZFN-induced DNA cleavage is highly specific. Meng et al. 2 , identify 41 regions of the zebrafish genome with sequences similar (differing by 1-4 nucleotides) to their intended ZFN target. Solexa sequencing of these regions in ZFNinjected embryos reveals that the rate of offtarget cleavage is ~1% in morphologically normal embryos and ~5% in embryos with nonspecific "monster" phenotypes. Doyon et al. 3 analyze the five genomic regions with sequences most similar to their intended target in progeny of ZFN-injected fish and detect no off-target cleavage.
Interestingly, Doyon et al. 3 observe that both copies of the targeted gene are disrupted in some cells of injected embryos, leading to mosaic mutant phenotypes. Meng et al. 2 , however, do not report mosaic phenotypes. Although the reason for this difference is unclear, one possibility is that Doyon et al. 3 use ZFNs with four zinc fingers whereas Meng et al. 2 use ZFNs containing three zinc fingers. Increasing the number of zinc fingers enhances the target specificity of ZFNs and can reduce off-target cleavage of DNA 4 . Accordingly, embryos injected by Doyon et al. 3 tolerate nanogram amounts of injected ZFN mRNA, whereas 50-pg doses of ZFN mRNA are toxic to most embryos in the Meng et al. 2 study. Hence, the higher levels of ZFNs used by Doyon et al. 3 may be sufficient to disrupt both copies of the targeted gene. Another reason for the difference may be that some mutant cells are more readily observable in a wild-type background than others-Doyon et al. 3 score obvious pigment and body pattern phenotypes, whereas Meng et al. 2 analyze more subtle vascular defects. Further work will clarify these issues.
How easily can this technology be implemented in a standard zebrafish lab? Injection, genotyping and mutant analysis are wellestablished procedures. Therefore, the remaining obstacles involve the design, selection and validation of ZFNs. Indeed, both studies stem from collaborations between zebrafish researchers and ZFN experts. Webbased tools 10 and published protocols 11 are available to assist researchers in designing and synthesizing ZFNs. It should be noted that the construction of modular ZFNs based on individual zinc finger-DNA interactions has been generally unsuccessful unless the repertoire of zinc fingers is restricted to those with particularly well-validated target sequences 12 . A commercial source of ZFN expertise, design and optimization is under development 3 .
Intriguingly, zebrafish embryos themselves might provide an excellent in vivo test and optimization system for ZFNs. The Meng et al. study 2 exemplifies this potential: ZFNs were designed such that a restriction enzyme recognition sequence was situated between their binding targets, enabling embryos to be tested for ZFN activity by PCR and restriction digestion shortly after injection. A skilled zebrafish researcher can inject and assay hundreds of embryos in a single day, thus allowing multiple candidate ZFNs to be tested in parallel.
It is likely that ZFNs will find widespread use in the zebrafish community and complement other approaches currently used to disrupt the function of specific genes 1 .
For example, antisense morpholino oligonucleotides can block translation or splicing of specific RNAs but often induce off-target effects and are unsuited for phenotypic analyses at later stages of development. True genetic mutants can be generated through TILLING, in which large libraries of mutagenized fish are screened by PCR and sequenced for lesions in target genes. Although specific regions within genes can be analyzed for disruptions, the mutations obtained by TILLING are random; moreover, the required resources are beyond the scope of most laboratories. Retroviral insertions have also been successfully used to disrupt zebrafish genes. Because each insert can be mapped within the genome, large collections of insertions could in principle be created with inserts in nearly every gene. However, the potential to specifically edit the zebrafish genome is unique to ZFNs.
In summary, Doyon et al. 3 and Meng et al. 2 convincingly demonstrate that ZFNs can induce mutations in zebrafish via nonhomologous end joining. The next step will be to coerce the DNA repair machinery to use homologous recombination, rather than nonhomologous end joining, to repair ZFNinduced double-strand breaks. Homologous recombination techniques would allow for exquisite control over mutagenesis and could also facilitate the introduction of transgenes that reflect endogenous gene expression and protein localization. Finally, the two studies suggest that ZFN technology can be applied to other organisms that have a sequenced genome and that are amenable to RNA injection. ZFNs might therefore become the major technology for genome manipulation. Screen for gene knockout Figure 1 Targeted mutagenesis of zebrafish genes with zinc-finger nucleases (ZFNs). Two ZFNs that target the locus of interest are generated through rational design and screening. mRNAs encoding the ZFNs are injected into zebrafish embryos at the one-cell stage. After cleavage of the target sequence, the endogenous repair machinery can religate the DNA through nonhomologous end joining, which often adds or deletes nucleotides at the cleavage site.
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